Efficacy and safety of sequential IV/PO moxifloxacin for the treatment of severe community-acquired pneumonia

Podobne knjige/članki

• Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study
  od: Schaper, N. C., et al.
  Izdano: (2012)
• Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI)
  od: Kuzman, Ilija, et al.
  Izdano: (2014)
• Moxifloxacin for Community-Acquired Pneumonia
  od: Rijnders, Bart J. A.
  Izdano: (2003)
• Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment
  od: Finch, R., et al.
  Izdano: (2002)
• Moxifloxacin Pharmacokinetic Profile and Efficacy Evaluation in Empiric Treatment of Community-Acquired Pneumonia
  od: Öbrink-Hansen, Kristina, et al.
  Izdano: (2015)